Ligand validation:9IKF

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9IKF_LFA_P_314	25%	94%	0.208	0.889	0.27	0.17	-	-	0	0	75%	0.6
9IKF_LFA_N_608	24%	86%	0.228	0.913	0.35	0.36	-	-	6	0	70%	0.6
9IKF_LFA_C_309	22%	96%	0.236	0.869	0.23	0.14	-	-	0	0	90%	0.4
9IKF_LFA_P_310	20%	95%	0.263	0.888	0.2	0.18	-	-	2	0	90%	0.4
9IKF_LFA_A_609	14%	92%	0.259	0.868	0.35	0.18	-	-	4	0	70%	0.6
9IKF_LFA_B_307	12%	91%	0.31	0.869	0.38	0.2	-	-	3	0	85%	0.6
9IKF_LFA_A_610	12%	75%	0.274	0.859	0.58	0.4	-	-	8	0	70%	0.6
9IKF_LFA_P_315	12%	91%	0.278	0.872	0.29	0.29	-	-	0	0	65%	0.6
9IKF_LFA_C_313	11%	85%	0.279	0.842	0.3	0.43	-	-	0	0	75%	0.6
9IKF_LFA_T_102	11%	96%	0.276	0.872	0.21	0.17	-	-	0	0	55%	0.6
9IKF_LFA_C_307	10%	94%	0.305	0.888	0.22	0.23	-	-	3	0	55%	0.4
9IKF_LFA_P_312	9%	96%	0.326	0.875	0.19	0.18	-	-	0	0	70%	0.5
9IKF_LFA_C_312	9%	93%	0.29	0.865	0.22	0.25	-	-	2	0	55%	0.5
9IKF_LFA_C_314	9%	94%	0.298	0.855	0.28	0.18	-	-	0	0	65%	0.6
9IKF_LFA_P_313	9%	94%	0.293	0.866	0.18	0.27	-	-	2	0	55%	0.5
9IKF_LFA_O_302	9%	94%	0.321	0.84	0.27	0.19	-	-	0	0	85%	0.6
9IKF_LFA_P_301	9%	98%	0.33	0.865	0.16	0.1	-	-	0	0	75%	0.4
9IKF_LFA_N_609	9%	73%	0.295	0.837	0.65	0.39	-	-	6	0	70%	0.6
9IKF_LFA_P_308	7%	96%	0.33	0.87	0.19	0.16	-	-	3	0	55%	0.4
9IKF_LFA_O_303	6%	98%	0.321	0.846	0.18	0.09	-	-	0	0	55%	0.6
9IKF_LFA_C_310	6%	99%	0.343	0.864	0.13	0.09	-	-	0	0	55%	0.5
9IKF_LFA_C_311	5%	95%	0.37	0.831	0.23	0.16	-	-	0	0	70%	0.5
9IKF_LFA_P_309	4%	97%	0.363	0.862	0.24	0.08	-	-	0	0	30%	0.4
9IKF_LFA_C_325	4%	99%	0.414	0.831	0.17	0.08	-	-	0	0	75%	0.4
9IKF_LFA_P_311	2%	99%	0.425	0.781	0.17	0.08	-	-	0	0	55%	0.5
9IKF_LFA_C_308	1%	98%	0.432	0.794	0.21	0.09	-	-	0	0	30%	0.4
9IKI_LFA_N_608	41%	91%	0.169	0.937	0.29	0.29	-	-	5	0	70%	0.6
9IKG_LFA_P_313	33%	92%	0.187	0.912	0.27	0.24	-	-	0	0	75%	0.6
9KUM_LFA_P_313	32%	90%	0.187	0.908	0.38	0.22	-	-	1	0	75%	0.6
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.4
9KUK_LFA_P_314	30%	86%	0.19	0.896	0.46	0.26	-	-	3	0	75%	0.6
9I6I_LFA_D_313	67%	69%	0.117	0.953	0.3	0.86	-	-	0	0	85%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
9I6H_LFA_C_309	61%	69%	0.136	0.926	0.29	0.88	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.